Nuclera Nucleics
PrivateLast Round
Series C
Jan 13, 2026
Est. Valuation
$17.09M
Total Funding Raised
$234.06M
Company Overview
Nuclera is a biotechnology company that offers an automated platform to enhance drug discovery workflows by enabling researchers to efficiently screen and synthesize proteins using integrated cell-free protein synthesis and digital microfluidics on smart cartridges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuclera Nucleics Comps
Public and private peers based on sector, stage, and business model.
Nuclera Nucleics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 13, 2026 | ||||
| Series C | Oct 16, 2024 | ||||
| Grant | Jun 6, 2024 | ||||
| Series B Extension | Jul 6, 2022 | ||||
| Series B | Feb 2, 2022 | ||||
Series A | Nov 1, 2018 |
Key People
Founding team and executive leadership
Nuclera Nucleics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Amadeus Capital Partners | Series B |
| Verve Ventures | Series B Extension, Series C |
| G. K. Goh Holdings Pte. Ltd. | Series C |
| Future Planet Capital Regional | Series B |
| Patient Square Capital | Series C |
| British Business Bank | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Launched nanodisc panel for GPCR screening and scale-up.
- Mar 29, 2026
Received an award at the One Nucleus Awards 2026.
Nuclera Nucleics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuclera Nucleics's valuation, stock price, and market status.
